Ayurveda gets the spotlight in new documentary, The Double Helix of Life
A powerful new documentary on Ayurveda—Ayurveda: The Double Helix of Life—just had its grand premiere in New Delhi. Clocking in at 90 minutes and shot in English, the film dives deep into how this ancient Indian system of medicine might just be the answer to some of modern healthcare's biggest challenges.
The premiere took place at the Film Division Theatre. Union Minister of State for AYUSH and Health & Family Welfare, Prataprao Jadhav, and AYUSH Secretary Rajesh Kotecha were there to do the honors, alongside a lineup of dignitaries from the health and wellness space.
The film, produced by Dr. A.V. Anoop under AVA Productions in collaboration with the
Ayurvedic Medicine
Manufacturers Organisation of India (AMMOI), is directed by Vinod Mankara.
Attendees included major voices in the Ayurvedic and medical world—Dr. P Ramkumar (AMMOI President), E.T. Neelakandan Moos (AMMOI Treasurer), Prof. Rabinarayan Acharya (Director General of CCRAS), Padma Shri Vaidya Balendu Prakash, Sanjay Shrivastava of Maharishi
Ayurveda
, and Promod Sharma from Baidyanath.
So, what's the big message? That Ayurveda isn't just about herbal powders and yoga poses—it's a holistic, preventive approach backed by actual research.
The film busts common myths that Ayurveda is all belief and no science, and instead shows how it's supported by over a thousand peer-reviewed studies, modern lab testing, and real-world case stories.
With chronic illnesses like diabetes, arthritis, and autoimmune diseases draining healthcare systems across the U.S., Germany, and Switzerland, The Double Helix of Life argues that Ayurveda offers something mainstream medicine often lacks—prevention.
And when it's supported by evidence, it's not just effective—it's cost-efficient and low on side effects too.
'Ayurveda gives us tools to not just treat, but prevent disease,' says Dr. A.V. Anoop. 'It's time to shift from managing symptoms to addressing root causes.'
Director Vinod Mankara adds, 'This film isn't just about looking back at tradition—it's about looking ahead. Ayurveda is already included in wellness insurance in countries like Germany and Switzerland. In India, it's part of the Ayushman Bharat mission. It can really ease the pressure on our public health system.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Why Twinkle Khanna's wry take on hot flushes strikes a chord with menopausal women
Twinkle Khanna's wit is unmatched. The former actor-turned-author's tongue-in-cheek comment on this menopause symptom recently struck a chord with many in that age bracket. The 51-year-old shared a picture of herself with her pet dog. 'Both of us are suffering. Me: Hot flushes. Him: Itchy ears. One of us is, as usual, chasing their own tail. Guess who,' she wrote. Soon, the comment on her Threads post gathered like-minded responses. 'Hot flushes are the worst. Hang in there Twinkle. Mood swings & all the other symptoms have to be endured……one day you will be just fine. Take care', one wrote, while another shared, 'Try Ayurveda Twinkle, worked for me like magic! Keep rocking as always'. Taking a cue from her admission, let's understand what hot flushes are and why they happen once menopause sets in. Twinkle Khanna's candid revelation brings attention to a natural yet often overlooked aspect of women's health, stressed Dr Shobha Gupta, founder, medical director and IVF specialist at Mumma's Blessing IVF and Birthing Paradise in Vrindavan. Sweating and skin reddening may result from hot flushes, which are abrupt sensations of warmth frequently strongest across the face, neck, and chest. 'Hormonal changes during menopause, especially the drop in oestrogen levels, are the main cause of them. The hypothalamus, which regulates body temperature, is impacted by this hormonal change and perceives the body as being overheated, which sets off cooling processes including vasodilation and perspiration,' said Dr Gupta. She emphasised the importance of understanding these symptoms. She explained, 'Hot flashes or hot flushes are a hallmark of menopause. Women experiencing such symptoms should consult with a healthcare professional to determine the most appropriate management plan tailored to their specific needs,' said Dr Gupta. Management strategies for hot flashes include lifestyle modifications such as wearing breathable clothing, avoiding known triggers like spicy foods and caffeine, and practicing stress-reduction techniques. 'In some cases, medical interventions like hormone replacement therapy or other medications may be recommended,' said Dr Gupta. Dr Gupta also highlighted the need for increased awareness and research on menopause and its symptoms. She noted, 'Many women suffer in silence due to a lack of information and support. It's crucial to have open conversations and provide resources to help them navigate this phase of life,' said Dr Gupta. DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.
Mint
an hour ago
- Mint
Growing obesity concerns prompt roll-out for measuring obesity among schoolchildren
New Delhi: India plans to roll-out a nationwide screening programme for measuring obesity among school children officials aware of the matter said. Children will be measured for their waist-to-hip ratio (WHR)—a body fat distribution metric calculated by dividing the waist circumference with the hip circumference. This key metric will be in addition to screening school children for their Body Mass Index (BMI), as part of a plan to prevent India from becoming home to the third-highest global obese population by 2050, after the US and China. A 2025 Lancet obesity forecasting study projects a staggering rise in overweight and obese adults in India from 180 million in 2021 to an estimated 449 million by 2050. In March, a government release highlighted that India already ranks second globally in childhood obesity, with over 14 million children affected. The development comes in the backdrop of growing concerns about youth obesity, with the education ministry communicating this plan to the health ministry for analyzing the outcomes to make necessary policy interventions. With one in five adults in urban areas being overweight or obese, the study aims to check the health hazard before it turns into an epidemic. 'Increased waist and hip ratio in children increases the risk of metabolic activities in children and type-2 diabetes later in life. During childhood they may or may not have indicators of metabolic syndrome but the risk increases significantly in these children in adulthood," said Dr N.K. Arora, senior paediatrician who is the President of AIIMS Deoghar. The World Health Organization (WHO) defines obesity as abnormal or excessive fat accumulation that poses a health risk, leading to serious non-communicable diseases like diabetes, hypertension, heart disease, and mental health issues. It also carries a substantial economic burden due to increased healthcare costs and reduced productivity. 'School children are often screened for classic BMI standards. So, now, during this screening BMI, waist to hip ratio will also be screened for kids which is a more accurate assessment. Especially for the Indian population, where an "oversized waist" is a common concern," said the official aware of the plan. "It has been found in India that the waist is mostly oversized in the population. So, waist-to-hip ratio is more indicative to diagnose obesity." "The immediate focus is on controlling childhood obesity and finding effective solutions," another official said. Prime Minister Narendra Modi, in January 2025, urged citizens to adopt active and healthy lifestyles and called for a 10% reduction in oil consumption. Last week, Union health secretary Punya Salila Srivastava in a letter proposed that all ministries and government departments display "sugar and oil boards" and print health messages on official stationery to promote healthier dietary habits and physical activity in offices. Dr. Sanjeev Bagai, a senior pediatrician and chairman at Nephron Clinics, highlighted the dramatic increase in childhood obesity, from 4-5% to 20-25% in children aged 15-18 years over the last two decades. "BMI is not an accurate way of measuring obesity. We need a more detailed evaluation which will determine truncal obesity versus peripheral obesity, which means waist to hip ratio." Bagai emphasized comprehensive school screenings that include height, weight, hip-to-waist ratio, BMI, blood pressure, and urine routine. "Each school should be mandated to furnish the record and these children be identified, tracked and monitored." Furthermore, he stressed the importance of integrating nutrition and dietetics into the school curriculum, supervising school meals, and educating parents on healthy food choices for their children. Queries sent to the health ministry and education ministry spokespersons remained unanswered.
Economic Times
an hour ago
- Economic Times
Big money is making a beeline for Indian hospitals
Indian hospitals are the new goldmine for deep pockets. Besides a rush of investment, a high-intensity consolidation is ongoing in India's hospital space. As per an ET report based on information from sources, IPO-bound Manipal Health Enterprises is leading the race to acquire Sahyadri Hospitals with a Rs 6,838 crore ($800 million) bid. Global investment firm Blackstone is a close second, sources said. IHH Healthcare-backed Fortis Healthcare and EQT Partners also submitted bids on June 23, which was the last day to submit binding financial bids. ADVERTISEMENT Also Read: Manipal Health Enterprises leads race to buy Sahyadri Hospitals The Pune-headquartered hospital chain, which operates 11 facilities across Pune, Nashik, Ahilya Nagar and Karad, comprising 1,300 beds, 2,500 clinicians and 3,500 support staff, is owned by Canada's pension fund Ontario Teachers' Pension Plan (OTPP), which had acquired Sahyadri from Everstone Capital in August 2022 at a valuation of around Rs 2,500 crore, outbidding Max Healthcare. Everstone had bought the hospital chain three years earlier in 2019 from its founder, neurosurgeon Charudutt Apte, for about Rs 1,000 crore. The big money chasing Sahyadri for past several years is emblematic of the attraction Indian hospitals, especially smaller chains, have come to hold in recent times. Bulge-bracket private equity funds are increasingly investing in single-specialty Indian hospital chains that present a robust growth potential in emerging consuming centers, significantly widening the addressable market beyond their traditional metropolitan bailiwicks, ET had reported in locations, such as Lucknow , Vizag, Jaipur, Cochin, Siliguri, Guwahati, Bhubaneswar and Patna, private equity investors believe, hold great growth potential in healthcare, in lockstep with an increasing affordability quotient in tier- 2 or 3 towns, and a greater availability of qualified doctors and specialists. PE funds are looking for players that will give higher returns - and blockbuster exits when the investments run their course. ADVERTISEMENT 'A trifecta of factors is helping accelerate investor interest in the single specialty healthcare chains including significant growth opportunity in tier 2/3 cities, clearly visible unit economics and viability with best in class ROIs,' Vishal Bali, executive chairman, Asia Healthcare Holdings (AHH), a leading healthcare investment platform, with focus on single specialities like oncology, women and child care, fertility, urology and nephrology, had told ET. 'AHH has been the inflection point for Single speciality healthcare with all our companies in single speciality healthcare delivering consistent growth in revenues, ebitda and geographical reach along with ROIs' he PE monies in treatment areas such as IVF, nephrology, eye-care, oncology, mother & childcare among others, have become a credible prescription for future value creation, after nearly a decade-long hunt for multi-speciality assets across the country. According to an analysis done by Avendus, single-speciality hospitals account for over 40% of all PE investments in healthcare since 2019. This was just a bit over 15% between 2015 and 2018. Between 2020 and early 2025, the segment recorded 24 PE/VC investments totalling $1.8 billion, with 19 of those deals worth $1.2 billion closing in the last two years alone, shows data put together by Grant Thornton. ADVERTISEMENT Over the period of two years from 2022-24 Hospitals in India have become one of the preferred investment destination for Investors, attracting net investment of $4.96 billion from Private Equity and $3.2 billion through Foreign Direct Investment (FDI). ADVERTISEMENT As per a report prepared by consultancy firm Grant Thornton Bharat in collaboration with the Association of Healthcare providers of India (AHPI), from 2022-24 hospitals in India undertook M&A deals worth $6.74 billion and attracted $4.96 billion from Private Equity (PE) investors. During the period, hospitals also raised $466 million through Initial Public Offering (IPO). The report which analysed 594 M&A and private equity transactions that took place during the period states that, 'Hospitals require diverse funding solutions to sustain growth, ranging from equity financing, debt financing, and foreign direct investment (FDI) to public-private partnerships (PPPs).' As per the investment analysis, the top three investment via PE route includes: Temasek Holdings $2 billion investment in Manipal Health (2023); $656 million by BPEA EQT in Indira IVF (2023); and lastly Blackstone Group $591.1 million investment in Quality Care (2023). A recent big deal was by a New York-based global private-equity and investment company, KKR, which in February bought a controlling stake in leading cancer care hospital chain Healthcare Global (HCG) from private equity peer CVC Capital Partners for nearly $400 million. By acquiring Baby Memorial Hospital last year, KKR made a comeback to the sector after one of its biggest paydays in India exiting Max Healthcare two years ago. ADVERTISEMENT Deal-making in India's healthcare sector has surged in recent years, with hospitals now commanding the largest share of foreign direct investment (FDI) within the sector, TOI had reported in December. In FY24, hospitals accounted for 50% of the FDI in total healthcare, translating to $1.5 billion. This marks a significant increase, as the share of hospitals in healthcare FDI has more than doubled from 24% in FY21, and has been rising from 43% in FY20, underscoring their growing prominence. The trend also reflects a strengthening investor preference for hospitals, alongside the traditionally favoured pharmaceuticals strong private equity interest in India's healthcare services companies is a highly credible indicator of the multi-decade growth potential inherent in the sector, as per a top executive at European investment bank Rothschild & Co. "We expect to see expansion of interest as international players evaluate the market and get more comfortable with the domestic landscape," Hedley Goldberg, partner and global head of healthcare services at Rothschild & Co, told ET in an interview in January. Besides a number of private equity deals, the hospital sector is also attracting big Indian businesses. While several corporates such as Tata, Birla and Hinduja have a presence in healthcare, none has made a significant pan-India presence. But the Bajaj Group is preparing to enter the healthcare sector by setting up a chain of hospitals in metros across the country., ET had reported last year. As per Bloomberg, it has earmarked Rs 10,000 crore as an initial investment. In recent years, healthcare companies and hospitals in India have been increasingly focussing on acquiring buildings and properties to expand their operations and strengthen their market presence. This trend is driven by the rising demand for quality healthcare services in urban and semi-urban areas, fuelled by a growing population, increasing health awareness and better insurance coverage. In December last year, billionaire Mukesh Ambani's Reliance Industries acquired technology-driven and oncology-focused healthcare platform Karkinos for Rs 375 crore. Reliance bought it under the Insolvency and Bankruptcy Code (IBC). The healthcare sector, particularly hospitals, witnessed major expansion during the Covid-19 pandemic. However, after the situation eased, it became difficult for many standalone hospitals to sustain their businesses. Such hospitals have been seeing interest from two sets of bidders — those already in the industry and seeking to expand and those who want to turn around such entities before they sell to someone else. Promoter-driven strategic investment firms and hospital operators are scouting for stressed healthcare assets that they can acquire through the insolvency and bankruptcy process, as private equity firms often edge them out in the race for good assets by offering lofty the pharmaceuticals sector, including APIs (active pharmaceutical ingredients), has been the investor favourite, attracting multi-billion-dollar deals. However, post-Covid, the hospital and diagnostics sector has come into the spotlight, drawing a wave of investors. The Indian hospital sector market cap surged 9x from Rs 37,500 crore in FY20 to Rs 3.5 lakh crore, brokerage firm JM Financial said last year in July. At a time when the sector was grappling with inefficiencies, high leverage and low ROCEs, Covid provided a much-needed impetus. This came from improved pricing, higher insurance coverage and dedicated shift towards complex surgeries such as transplants. India's top listed hospital chains performed well in the stock market leading up to this year. Apollo Hospitals' shares climbed 28% in 2024, while Max Healthcare Institute Ltd. soared 64%. The Indian hospital industry is poised to post a healthy compound annual growth rate (CAGR) of about 12% over the next three fiscal years, credit rating agency CareEdge Ratings said last year. Growing incidence of lifestyle diseases and easing demand for affordable health care delivery are driving the healthcare market in India. A report released last year by HSBC Global Research on India hospitals said seven listed hospitals will add 14,000 beds in the next 3-5 years. A total of 22,000 new beds is expected, including those by other private hospital chains. Even with these additions, there will be no over-supply of beds in India. The report said that the addition of beds is triple the number of beds added between FY19-24 at 4,000. Most hospitals are now in a consolidation phase and planning to expand and add sees growth opportunities after making profits between FY19-24 because of low capex. A World Health Organisation (WHO) report said last year that India has only 16 beds per 10,000 people, which is abysmally low if compared with most of the developed and emerging markets. India requires 100,000 additional beds in the next 5-7 years just to meet its healthcare demand on the back of increasing non-communicable diseases such as diabetes, cardiac disorders, and cancer., as per the HSBC report. The government's push to turn India into a global healthcare hub by promoting medical tourism is another strong growth driver for the hospital sector.
